 Travere Therapeutics, Inc. NASDAQ:TVTX Q3 2022 Earnings Conference Call October 27, 2022 4:30 PM ET Company Participants Naomi Eichenbaum - Vice President, Investor Relations Eric Dube - President and Chief Executive Officer Jula Inrig - Chief Medical Officer Peter Heerma - Chief Commercial Officer Chris Cline - Chief Financial Officer William Rote - Senior Vice President of Research and Development Conference Call Participants Maurice Raycroft - Jefferies Greg Harrison - Bank of America Tim Lugo - William Blair Liisa Bayko - Evercore ISI Laura Chico - Wedbush Securities Ed Arce - H.C. Wainwright Co. Operator Good day and welcome to the Travere Therapeutics Third Quarter 2022 Financial Results and Corporate Update Conference Call. 